Alliancebernstein L.P. Has $296.31 Million Stock Holdings in Corteva, Inc. $CTVA

Alliancebernstein L.P. lifted its position in shares of Corteva, Inc. (NYSE:CTVA) by 3.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,381,340 shares of the company’s stock after purchasing an additional 125,690 shares during the period. Alliancebernstein L.P. owned about 0.65% of Corteva worth $296,310,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in CTVA. Vanguard Group Inc. grew its holdings in Corteva by 0.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock worth $5,976,436,000 after acquiring an additional 373,680 shares during the last quarter. Franklin Resources Inc. increased its position in Corteva by 5.9% in the 3rd quarter. Franklin Resources Inc. now owns 18,731,627 shares of the company’s stock valued at $1,266,820,000 after acquiring an additional 1,051,389 shares during the period. Norges Bank bought a new position in shares of Corteva during the second quarter valued at $434,220,000. Legal & General Group Plc lifted its holdings in shares of Corteva by 14.3% during the third quarter. Legal & General Group Plc now owns 5,753,982 shares of the company’s stock worth $389,142,000 after purchasing an additional 720,469 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Corteva by 1.4% during the second quarter. JPMorgan Chase & Co. now owns 5,078,034 shares of the company’s stock worth $378,466,000 after purchasing an additional 68,996 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA opened at $79.13 on Monday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm’s fifty day simple moving average is $74.11 and its two-hundred day simple moving average is $69.17. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $80.90. The stock has a market capitalization of $53.22 billion, a P/E ratio of 50.08, a price-to-earnings-growth ratio of 2.71 and a beta of 0.72.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same period last year, the company posted $0.32 EPS. The business’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is presently 45.57%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on CTVA shares. Wolfe Research increased their price objective on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft upped their price target on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Finally, Jefferies Financial Group lifted their price objective on Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 0.15% of the stock is currently owned by company insiders.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.